| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
8 |
| issn |
1179-190X
1173-8804 |
| issueIdentifier |
1 |
| pageRange |
1-8 |
| publicationName |
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy |
| startingPage |
1 |
| bibliographicCitation |
Gu W, Li Y. The therapeutic potential of the adiponectin pathway. BioDrugs. 2012 Feb 01;26(1):1–8. doi: 10.2165/11594790-000000000-00000. PMID: 22050309. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20d59fb9ec8ea1457f56c337c7998d62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23e1ee6cad9086b224c84f100a77705e |
| date |
2012-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/22050309
https://doi.org/10.2165/11594790-000000000-00000 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1179-190X
https://portal.issn.org/resource/ISSN/1173-8804
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22420 |
| language |
English |
| source |
https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
The Therapeutic Potential of the Adiponectin Pathway |
| discusses |
http://id.nlm.nih.gov/mesh/M0260436 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ed78d0be481e34f2b5c952862a782905
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_74421fdbd10e1365dbfc6e6e3a62a2f9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_67be0b057f2811fe207568ef01325eda
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ae5aaeb4d7dce1bb13a6412790c67b97
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9eff1565e020a15efe4b99df1d3075d4
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.23 |